NCT07077252View on ClinicalTrials.gov

Phase I/II Study of SCTB39G in Advanced Solid Tumours

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

September 26, 2027

Study Completion Date

October 17, 2027

Conditions

Advanced Malignant Solid Tumor

Interventions

DRUG

SCTB39G

SCTB39G,IV

Trial Locations (1)

100412

Beijing Cancer Hospital, Beijing

All Listed Sponsors

lead

Sinocelltech Ltd.

INDUSTRY